MARKET

ATRS

ATRS

Antares Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.090
-0.270
-11.44%
Closed 16:11 04/01 EDT
OPEN
2.270
PREV CLOSE
2.360
HIGH
2.280
LOW
2.060
VOLUME
1.79M
TURNOVER
--
52 WEEK HIGH
5.13
52 WEEK LOW
1.600
MARKET CAP
346.02M
P/E (TTM)
-155.9701
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ATRS stock price target is 6.50 with a high estimate of 9.00 and a low estimate of 5.00.

EPS

ATRS News

More
  • Edited Transcript of ATRS earnings conference call or presentation 3-Mar-20 1:30pm GMT
  • Thomson Reuters StreetEvents · 03/22 05:20
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Raymond James Maintains Strong Buy on Antares Pharma, Raises Price Target to $6
  • Benzinga · 03/04 12:22
  • Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/03 20:15

Industry

Medical Equipment, Supplies & Distribution
-4.79%
Healthcare Equipment & Supplies
-4.98%

Hot Stocks

Symbol
Price
%Change

About ATRS

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
More

Webull offers kinds of Antares Pharma Inc stock information, including NASDAQ:ATRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRS stock news, and many more online research tools to help you make informed decisions.